X
HZNP

Xponance’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Xponance’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,120
Closed -$3.37M – 1301
2023
Q3 		$3.37M Buy
29,120
+449
+2% +$48.2K 0.05% 327
2023
Q2 		$2.95M Sell
28,671
-86
-0.3% -$9.07K 0.04% 366
2023
Q1 		$3.14M Buy
28,757
+171
+0.6% +$18.9K 0.05% 354
2022
Q4 		$3.25M Buy
28,586
+3,588
+14% +$298K 0.05% 319
2022
Q3 		$1.55M Buy
24,998
+160
+0.6% +$11.2K 0.03% 451
2022
Q2 		$1.98M Buy
24,838
+18,124
+270% +$1.72M 0.04% 375
2022
Q1 		$706K Buy
6,714
+175
+3% +$17.1K 0.01% 739
2021
Q4 		$705K Sell
6,539
-40
-0.6% -$4.36K 0.01% 765
2021
Q3 		$721K Sell
6,579
-809
-11% -$84K 0.01% 710
2021
Q2 		$692K Sell
7,388
-11,585
-61% -$1.07M 0.01% 764
2021
Q1 		$1.75M Buy
18,973
+237
+1% +$20K 0.04% 344
2020
Q4 		$1.37M Sell
18,736
-276
-1% -$20.5K 0.03% 390
2020
Q3 		$1.48M Buy
19,012
+1,353
+8% +$93.1K 0.04% 339
2020
Q2 		$981K Buy
+17,659
New +$755K 0.03% 388

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Xponance's HZNP Position: Q4 2023 in Review

Xponance sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 29,120 shares — an estimated $3.37M sold.

Xponance first reported a position in HZNP in Q2 2020 and held it in 14 quarters. The position peaked at $3.37M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Xponance reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Xponance sold 29,120 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.37M.
  • Xponance first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 14 quarters.
  • Xponance's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.37M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Xponance's 13F filing for Q4 2023, filed 31 Jan 2024.